Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis) (GPBA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02323100
Recruitment Status : Recruiting
First Posted : December 23, 2014
Last Update Posted : July 15, 2019
University of Alabama at Birmingham
Children's Hospital of Philadelphia
Johns Hopkins University
Horizon Pharma Ireland, Ltd., Dublin Ireland
Information provided by (Responsible Party):
Pam Zeitlin, National Jewish Health

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 30, 2021
Estimated Study Completion Date : June 30, 2021